Puma Biotechnology, Inc.

Direct answer

Puma Biotechnology, Inc. is publicly traded on NASDAQ under the ticker PBYI.

Puma Biotechnology, Inc. is a biopharmaceutical company dedicated to the global development and commercialization of treatments aimed at advancing cancer care. Its lead drug candidate, orally administered neratinib (PB272), targets a range of indications. These include patients with early-stage HER2-overexpressed/amplified breast cancer, as well as adults suffering from advanced or metastatic HER2-positive breast...

Can you invest in Puma Biotechnology, Inc.?

Yes. Puma Biotechnology, Inc. is publicly traded on NASDAQ under the ticker PBYI.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Puma Biotechnology, Inc.

Detailed equity research is provided by MarketSnap.